News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Camardo Daniel A.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/06/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Paid exercise price by delivering 19,993 shares
@ $0.44, valued at
$8.8k
|
|
07/06/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Paid exercise price by delivering 19,993 shares
@ $0.914, valued at
$18.3k
|
|
04/05/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Paid exercise price by delivering 19,993 shares
@ $1, valued at
$20k
|
|
01/06/2023 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Paid exercise price by delivering 23,484 shares
@ $0.85, valued at
$20k
|
|
11/22/2022 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Bought 100,000 shares
@ $0.5496, valued at
$55k
|
|
10/06/2022 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Granted 263,492 shares
@ $0 |
|
03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2022 |
4
| Camardo Daniel A. (CEO) has filed a Form 4 on ATHERSYS, INC / NEW
Txns:
| Granted 4,000,000 options to buy
@ $0.86, valued at
$3.4M
|
|
04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/06/2020 |
4
| Camardo Daniel A. (EVP and President, U.S.) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns:
| Sold 3,500 shares
@ $76.7609, valued at
$268.7k
|
|
10/22/2020 |
4
| Camardo Daniel A. (EVP and President, U.S.) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns:
| Granted 10,000 shares
@ $0 Paid exercise price by delivering 4,460 shares
@ $80.42, valued at
$358.7k
Exercised 10,000 restricted stock units
@ $0 |
|
|
|